Immune Response Activation and Neurotoxicity after Intrathecal Infusion of AAV9 Vector Encoding a Non-Self Reporter Protein in the Non-Human Primate

被引：0
|
作者：
Samaranch, Lluis [1 ]
San Sebastian, Waldy [1 ]
Kells, Adrian P. [1 ]
Bringas, John [1 ]
Pivirotto, Phillip [1 ]
Forsayeth, John [1 ]
Bankiewicz, Krystof S. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
594
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 28 条
  • [1] Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune Responses
    Ciesielska, Agnieszka
    Hadaczek, Piotr
    Mittermeyer, Gabriele
    Zhou, Shangzhen
    Wright, J. Fraser
    Bankiewicz, Krystof S.
    Forsayeth, John
    MOLECULAR THERAPY, 2013, 21 (01) : 158 - 166
  • [2] Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation
    Ramsingh, Arlene I.
    Gray, Steven J.
    Reilly, Andrew
    Koday, Michael
    Bratt, Debbie
    Koday, Merika Treants
    Murnane, Robert
    Smedley, Jeremy
    Hu, Yuhui
    Messer, Anne
    Fuller, Deborah Heydenburg
    PLOS ONE, 2018, 13 (06):
  • [3] A Non-Human Primate Biodistribution Study Comparing Multiple Routes of Administration of AAV9
    Daily, Jennifer L.
    Burstein, Suzanne R.
    Keiser, Nicholas W.
    Cobb, Stuart R.
    MOLECULAR THERAPY, 2021, 29 (04) : 171 - 172
  • [4] Optimization of intrathecal delivery of an infused AAV9 vector for delivery of a gene therapy candidate for adrenomyeloneuropathy in non-human primates
    Vasireddy, V.
    Clark, S. W.
    Anderson, D. W.
    Kozarsky, K.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A27 - A27
  • [5] Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
    Colle, Marie-Anne
    Piguet, Francoise
    Bertrand, Lise
    Raoul, Sylvie
    Bieche, Ivan
    Dubreil, Laurence
    Sloothaak, Didi
    Bouquet, Celine
    Moullier, Philippe
    Aubourg, Patrick
    Cherel, Yan
    Cartier, Nathalie
    Sevin, Caroline
    HUMAN MOLECULAR GENETICS, 2010, 19 (01) : 147 - 158
  • [6] Optimization of Intrathecal Delivery of an Infused AAV9 Vector for Delivery of a Gene Therapy Candidate for Adrenomyeloneuropathy (AMN) in Non-Human Primates (NHP)
    Vasireddy, Vidyullatha
    Clark, Sean W.
    Anderson, David W.
    Kozarsky, Karen
    MOLECULAR THERAPY, 2022, 30 (04) : 435 - 436
  • [7] Cardiac Toxicity of AAV9 Vector Upon Heart-Specific Expression of an Immunogenic Non-Self Transgene
    Park, Andrew
    Urakami, Akane
    Alfaro, Alex
    Wu, Herren
    Ikeda, Yasuhiro
    MOLECULAR THERAPY, 2020, 28 (04) : 47 - 47
  • [8] Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation (vol 13, e0198154, 2018)
    Ramsingh, Arlene I.
    Gray, Steven J.
    Reilly, Andrew
    Koday, Michael
    Bratt, Debbie
    Koday, Merika Treants
    Munson, Paul
    Murnane, Robert
    Smedley, Jeremy
    Hu, Yuhui
    Messer, Anne
    Fuller, Deborah Heydenburg
    PLOS ONE, 2018, 13 (11):
  • [9] Early distribution of 18F-labeled AAV9 vectors in the cerebrospinal fluid after intracisternal infusion in non-human primates
    Kumagai, S.
    Nakajima, T.
    Shimazaki, K.
    Kakiuchi, T.
    Harada, N.
    Ohba, H.
    Takino, N.
    Ito, M.
    Onuki, Y.
    Sato, M.
    Nakamura, S.
    Osaka, H.
    Yamagata, T.
    Kawai, K.
    Muramatsu, S.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A90 - A90
  • [10] Detection and Characterization of Immune Response Against AAVrh10 Vector After Intrathecal Vector Delivery in Non-Human Primates
    Gernoux, Gwladys
    Borel, Florie
    Gao, Guangping
    Brown, Robert
    Mueller, Christian
    MOLECULAR THERAPY, 2015, 23 : S39 - S39
123